Browsing CAT - Articles científics by Issue Date

The state of multiple sclerosis: current insight into the patient/health care provider relationship, treatment challenges, and satisfaction

Tintore Subirana, Mar; Alexander, Maggie; Costello, Kathleen; Duddy, Martin; Jones, David E; Law, Nancy (Dove Medical Press, 2016-12-22)

Clinical practice of analysis of anti-drug antibodies against interferon beta and natalizumab in multiple sclerosis patients in Europe: A descriptive study of test results

Link, Jenny; Ramanujam, Ryan; Auer, Michael; Ryner, Malin; Hassler, Signe; Bachelet, Delphine; Fissolo, Nicolás Miguel; Montalban Gairín, Xavier; Comabella Lopez, Manuel (Public Library of Science, 2017-02-07)

Oligoclonal bands increase the specificity of MRI criteria to predict multiple sclerosis in children with radiologically isolated syndrome

Makhani, Naila; Lebrun, Christine; Siva, Aksel; Narula, Sona; Wassmer, Evangeline; Brassat, David; Tintore Subirana, Mar (SAGE Publications, 2019-03-20)

Traffic Lights Intervention Reduces Therapeutic Inertia: A Randomized Controlled Trial in Multiple Sclerosis Care

Saposnik, Gustavo; Mamdani, Muhammad; Montalban Gairín, Xavier; Terzaghi, Maria A; Silva, Berenice; Saladino, Maria Laura (SAGE Publications, 2019-06-21)

Adherence and satisfaction of smartphone- and smartwatch-based remote active testing and passive monitoring in people with multiple sclerosis: nonrandomized interventional feasibility study

Midaglia Fernandez, Luciana; Mulero Carrillo, Patricia; Montalban Gairín, Xavier; Graves, Jennifer; Hauser, Stephen L.; Julian, Laura (JMIR Publications, 2019-08-30)

Retinal inner nuclear layer volume reflects inflammatory disease activity in multiple sclerosis: a longitudinal OCT study

Balk, Lisanne J; Coric, Danko; Knier, Benjamin; Zimmermann, Hanna G; Behbehani, Raed; Alroughani, Raed; Vidal Jordana, Angela; Montalban Gairín, Xavier (SAGE Publications, 2019-09-05)

Critical role of interleukin (IL)-17 in inflammatory and immune disorders: An updated review of the evidence focusing in controversies

Ruiz de Morales, José María G.; Puig, Lluís; Daudén, Esteban; Cañete, Juan D.; Pablos, José Luis; Olveira Martín, Antonio; Montalban Gairín, Xavier; Borruel Sainz, Natalia; Orti Pascual, Guillem (Elsevier, 2020-01)

Recomendaciones para la vacunación en pacientes con esclerosis múltiple candidatos a terapias inmunosupresoras: documento de consenso español

Otero Romero, Susana; Rodríguez-García, J.; Vilella, A.; Ara Callizo, José Ramón; Brieva Ruiz, Luis; Calles, C.; Tintore Subirana, Mar (Elsevier, 2021-01)

Chitinases and chitinase-like proteins as biomarkers in neurologic disorders

Pinteac, Rucsanda; Montalban Gairín, Xavier; Comabella Lopez, Manuel (Lippincott Williams & Wilkins, 2021-01)

A R-Script for Generating Multiple Sclerosis Lesion Pattern Discrimination Plots

Marschallinger, Robert; Tur Gomez, Carmen; Marschallinger, Hannes; Sellner, Johann (MDPI, 2021-01-12)

Effect of Ozanimod on Symbol Digit Modalities Test Performance in Relapsing MS

DeLuca, John; Schippling, Sven; Montalban Gairín, Xavier; Kappos, Ludwig; Cree, Bruce; Comi, Giancarlo (Elsevier, 2021-02)

CSF SERPINA3 Levels Are Elevated in Patients With Progressive MS

Fissolo, Nicolás Miguel; Matute Blanch, Clara; Osman, Mohamoud; Costa Riu, Carme; Pinteac, Rucsanda; Miró Cau, Berta; Sánchez Pla, Alex; Brito, Veronica Ines; Montalban Gairín, Xavier; Comabella Lopez, Manuel (Wolters Kluwer Health, 2021-03)

Deciphering Multiple Sclerosis Progression

Berenguer-Ruiz, Leticia; Carreres-Polo, Joan; Eichau-Madueño, Sara; Ferrer-Lozano, Jaime; Forero, Lucía; Vidal Jordana, Angela; Meca-Lallana, Virginia (Frontiers Media, 2021-04)

The role of pontine lesion location in differentiating multiple sclerosis from vascular risk factor-related small vessel disease

Geraldes, Ruth; Juryńczyk, Maciej; Passos, Giordani; Pichler, Alexander; Chung, Karen; Hagens, Marloes; Auger Acosta, Cristina; Rovira Cañellas, Alex; Sastre Garriga, Jaume (SAGE Publications, 2021-05)

Ozanimod in relapsing multiple sclerosis: Pooled safety results from the clinical development program

Selmaj, Krzysztof W.; Cohen, Jeffrey A; Comi, Giancarlo; Bar-Or, Amit; Arnold, Douglas L; Steinman, Lawrence; Montalban Gairín, Xavier (Elsevier, 2021-06)

Angiogenin in the Neurogenic Subventricular Zone After Stroke

Gabriel Salazar, Marina; Lei (Santiago), Ting; Grayston Morales, Alba; Costa Riu, Carme; Medina Gutierrez, Esperanza; Montaner Villalonga, Joan; Rosell Novel, Anna; Comabella Lopez, Manuel (Frontiers Media, 2021-06-21)

SARS-CoV-2 Infection in Multiple Sclerosis: Results of the Spanish Neurology Society Registry

Arrambide García, Georgina; Llaneza González, Miguel Ángel; Costa-Frossard França, Lucienne; Fernández-Díaz, Eva; Moreno Torres, Irene; Meca-Lallana, Virginia (Lippincott Williams & Wilkins, 2021-06-24)

Use of Disease-Modifying Therapies in Pediatric Relapsing-Remitting Multiple Sclerosis in the United Kingdom

Abdel-Mannan, Omar; Manchoon, Celeste; Rossor, Thomas; Southin, Justine-Clair; TUR, CARMEN; Brownlee, Wallace (Lippincott Williams & Wilkins, 2021-07)

Serum Neurofilament Levels and PML Risk in Patients With Multiple Sclerosis Treated With Natalizumab

Fissolo, Nicolás Miguel; Pignolet, Beatrice; Rio Izquierdo, Jordi; Vermersch, Patrick; Ruet, Aurélie; deSèze, Jerome; Montalban Gairín, Xavier; Comabella Lopez, Manuel (Lippincott Williams & Wilkins, 2021-07)

Identification of the Immunological Changes Appearing in the CSF During the Early Immunosenescence Process Occurring in Multiple Sclerosis

Picón, Carmen; Tejeda-Velarde, Amalia; Fernández-Velasco, José Ignacio; Álvarez-Lafuente, Roberto; Quintana, Ester; Matute Blanch, Clara; Espejo Ruiz, Carmen; Comabella Lopez, Manuel (Frontiers Media, 2021-07)

Scientia. Dipòsit d'Informació Digital del Departament de Salut

Browsing CEMCAT - Articles científics by Issue Date

The state of multiple sclerosis: current insight into the patient/health care provider relationship, treatment challenges, and satisfaction

Clinical practice of analysis of anti-drug antibodies against interferon beta and natalizumab in multiple sclerosis patients in Europe: A descriptive study of test results

Oligoclonal bands increase the specificity of MRI criteria to predict multiple sclerosis in children with radiologically isolated syndrome

Traffic Lights Intervention Reduces Therapeutic Inertia: A Randomized Controlled Trial in Multiple Sclerosis Care

Adherence and satisfaction of smartphone- and smartwatch-based remote active testing and passive monitoring in people with multiple sclerosis: nonrandomized interventional feasibility study

Retinal inner nuclear layer volume reflects inflammatory disease activity in multiple sclerosis: a longitudinal OCT study

Critical role of interleukin (IL)-17 in inflammatory and immune disorders: An updated review of the evidence focusing in controversies

Recomendaciones para la vacunación en pacientes con esclerosis múltiple candidatos a terapias inmunosupresoras: documento de consenso español

Chitinases and chitinase-like proteins as biomarkers in neurologic disorders

A R-Script for Generating Multiple Sclerosis Lesion Pattern Discrimination Plots

Effect of Ozanimod on Symbol Digit Modalities Test Performance in Relapsing MS

CSF SERPINA3 Levels Are Elevated in Patients With Progressive MS

Deciphering Multiple Sclerosis Progression

The role of pontine lesion location in differentiating multiple sclerosis from vascular risk factor-related small vessel disease

Ozanimod in relapsing multiple sclerosis: Pooled safety results from the clinical development program

Angiogenin in the Neurogenic Subventricular Zone After Stroke

SARS-CoV-2 Infection in Multiple Sclerosis: Results of the Spanish Neurology Society Registry

Use of Disease-Modifying Therapies in Pediatric Relapsing-Remitting Multiple Sclerosis in the United Kingdom

Serum Neurofilament Levels and PML Risk in Patients With Multiple Sclerosis Treated With Natalizumab

Identification of the Immunological Changes Appearing in the CSF During the Early Immunosenescence Process Occurring in Multiple Sclerosis

Know Scientia

Guides and help

Go to...

Know Scientia

Guides and help

Go to...

Browsing CEMCAT - Articles científics by Issue Date

The state of multiple sclerosis: current insight into the patient/health care provider relationship, treatment challenges, and satisfaction ﻿

Clinical practice of analysis of anti-drug antibodies against interferon beta and natalizumab in multiple sclerosis patients in Europe: A descriptive study of test results ﻿

Oligoclonal bands increase the specificity of MRI criteria to predict multiple sclerosis in children with radiologically isolated syndrome ﻿

Traffic Lights Intervention Reduces Therapeutic Inertia: A Randomized Controlled Trial in Multiple Sclerosis Care ﻿

Adherence and satisfaction of smartphone- and smartwatch-based remote active testing and passive monitoring in people with multiple sclerosis: nonrandomized interventional feasibility study ﻿

Retinal inner nuclear layer volume reflects inflammatory disease activity in multiple sclerosis: a longitudinal OCT study ﻿

Critical role of interleukin (IL)-17 in inflammatory and immune disorders: An updated review of the evidence focusing in controversies ﻿

Recomendaciones para la vacunación en pacientes con esclerosis múltiple candidatos a terapias inmunosupresoras: documento de consenso español ﻿

Chitinases and chitinase-like proteins as biomarkers in neurologic disorders ﻿

A R-Script for Generating Multiple Sclerosis Lesion Pattern Discrimination Plots ﻿

Effect of Ozanimod on Symbol Digit Modalities Test Performance in Relapsing MS ﻿

CSF SERPINA3 Levels Are Elevated in Patients With Progressive MS ﻿

Deciphering Multiple Sclerosis Progression ﻿

The role of pontine lesion location in differentiating multiple sclerosis from vascular risk factor-related small vessel disease ﻿

Ozanimod in relapsing multiple sclerosis: Pooled safety results from the clinical development program ﻿

Angiogenin in the Neurogenic Subventricular Zone After Stroke ﻿

SARS-CoV-2 Infection in Multiple Sclerosis: Results of the Spanish Neurology Society Registry ﻿

Use of Disease-Modifying Therapies in Pediatric Relapsing-Remitting Multiple Sclerosis in the United Kingdom ﻿

Serum Neurofilament Levels and PML Risk in Patients With Multiple Sclerosis Treated With Natalizumab ﻿

Identification of the Immunological Changes Appearing in the CSF During the Early Immunosenescence Process Occurring in Multiple Sclerosis ﻿

Know Scientia

Guides and help

Go to...

Know Scientia

Guides and help

Go to...

The state of multiple sclerosis: current insight into the patient/health care provider relationship, treatment challenges, and satisfaction

Clinical practice of analysis of anti-drug antibodies against interferon beta and natalizumab in multiple sclerosis patients in Europe: A descriptive study of test results

Oligoclonal bands increase the specificity of MRI criteria to predict multiple sclerosis in children with radiologically isolated syndrome

Traffic Lights Intervention Reduces Therapeutic Inertia: A Randomized Controlled Trial in Multiple Sclerosis Care

Adherence and satisfaction of smartphone- and smartwatch-based remote active testing and passive monitoring in people with multiple sclerosis: nonrandomized interventional feasibility study

Retinal inner nuclear layer volume reflects inflammatory disease activity in multiple sclerosis: a longitudinal OCT study

Critical role of interleukin (IL)-17 in inflammatory and immune disorders: An updated review of the evidence focusing in controversies

Recomendaciones para la vacunación en pacientes con esclerosis múltiple candidatos a terapias inmunosupresoras: documento de consenso español

Chitinases and chitinase-like proteins as biomarkers in neurologic disorders

A R-Script for Generating Multiple Sclerosis Lesion Pattern Discrimination Plots

Effect of Ozanimod on Symbol Digit Modalities Test Performance in Relapsing MS

CSF SERPINA3 Levels Are Elevated in Patients With Progressive MS

Deciphering Multiple Sclerosis Progression

The role of pontine lesion location in differentiating multiple sclerosis from vascular risk factor-related small vessel disease

Ozanimod in relapsing multiple sclerosis: Pooled safety results from the clinical development program

Angiogenin in the Neurogenic Subventricular Zone After Stroke

SARS-CoV-2 Infection in Multiple Sclerosis: Results of the Spanish Neurology Society Registry

Use of Disease-Modifying Therapies in Pediatric Relapsing-Remitting Multiple Sclerosis in the United Kingdom

Serum Neurofilament Levels and PML Risk in Patients With Multiple Sclerosis Treated With Natalizumab

Identification of the Immunological Changes Appearing in the CSF During the Early Immunosenescence Process Occurring in Multiple Sclerosis